recent drop due to data from Alzheimer’s drug trial data. There are still ongoing trials with better results including another Alzheimer’s trial and a schizophrenia trial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
